Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 25, 2021

SELL
$145.58 - $192.14 $84,727 - $111,825
-582 Closed
0 $0
Q2 2021

Jul 26, 2021

SELL
$134.22 - $202.37 $56,103 - $84,590
-418 Reduced 41.8%
582 $372,000
Q1 2021

Apr 27, 2021

BUY
$140.25 - $196.86 $140,250 - $196,860
1,000 New
1,000 $605,000
Q4 2020

Jan 26, 2021

SELL
$126.47 - $163.7 $63,235 - $81,850
-500 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$87.44 - $125.0 $43,720 - $62,500
500 New
500 $62,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.43B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.